CMS Issues Final Rule CMS-4215-F Codifying Medicare Drug Price Negotiation Guidance, Effective December 5, 2026
The Centers for Medicare & Medicaid Services (CMS) on November 5 issued a final rule (CMS-4215-F) that codifies the operating guidance for the Medicare Drug Price Negotiation Program into regulation, covering negotiation cycles for initial price applicability years 2029 and beyond. The rule takes effect on December 5, 2026.
The negotiation program was created by sections 11001 and 11002 of the Inflation Reduction Act, authorizing the federal government to negotiate "maximum fair prices" directly with manufacturers for a set of high-spending brand-name drugs covered under Medicare Part D. Operational details for earlier cycles were issued mainly through annual guidance documents; the final rule now writes that guidance into the Code of Federal Regulations for greater stability and predictability.
CMS said the rule spells out how drugs are selected, how negotiations proceed, and how negotiated prices take effect and are enforced. Negotiated prices apply to Medicare beneficiaries and do not directly set commercial insurance prices, though the market watches the program for its wider signaling effect on drug pricing.
Drug price negotiation has been a focal point for the pharmaceutical industry since its first cycle, with debate over drug selection, discount levels and effects on research investment. The next negotiation cycle will proceed under the new rule, with CMS to announce selected drugs and the timeline for the 2029 price applicability year. (Source: Centers for Medicare & Medicaid Services)
Source: Centers for Medicare & Medicaid Services
Published by GSM · USA (original Chinese edition)
Photo: Medicare 医保卡样本（资料图），美国医疗保险和医疗补助服务中心，公共领域
CMS Proposes CARE Rule, CMS-3484-P, to Cut Administrative Requirements Across Hospitals and Health Care Facilities2026-11-11
FDA Issues Early Alert on November 10: Intersurgical Removes 22mm Smoothbore Breathing Tubes, Connectors May Detach, No Serious Injuries or Deaths Reported as of November 32026-11-10